Vagus nerve stimulation. . .25 years later! What do we know about the effects on cognition?

Neuroscience and Biobehavioral Reviews

Volumn 45, Issue , 2014, Pages 63-71

  Vonck, Kristl ^a   Raedt, Robrecht ^a   Naulaerts, Joke ^a   De Vogelaere, Frederick ^a   Thiery, Evert ^a   Van Roost, Dirk ^a   Aldenkamp, Bert ^b,c   Miatton, Marijke ^a   Boon, Paul ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Cognitive functioning; Depression; Epilepsy; Locus coeruleus; Memory; Norepinephrine; Quality of life; Vagus nerve stimulation

Indexed keywords

AMYLOID BETA PROTEIN; NORADRENALIN; TAU PROTEIN;

ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ALZHEIMER DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; AUDITORY RECOGNITION INDEX; AVOIDANCE BEHAVIOR; BASOLATERAL AMYGDALA; CEREBROSPINAL FLUID; COGNITION; DECISION MAKING; DENTATE GYRUS; DEPRESSION; DISEASE ASSOCIATION; EPILEPSY; EXECUTIVE FUNCTION; EXPERIMENTAL STUDY; GOTTFRIES BRANE STEEN SCALE; HOPKINS VERBAL LEARNING TEST; HUMAN; INVENTORY DEPRESSIVE SYMPTOMATOLOGY SELF REPORT; LANGUAGE; LEARNING; LEARNING TEST; LONG TERM CARE; LONG TERM POTENTIATION; MEMORY; MEMORY CONSOLIDATION; MEMORY OBSERVATION QUESTIONNAIRE; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; MISMATCH NEGATIVITY; MONTGOMETRY ASBERG DEPRESSION RATING SCALE; MOOD; MOTION; NEUROCHEMISTRY; NEUROPSYCHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROFILE MOOD STATES; PROTEIN PHOSPHORYLATION; PSYCHOMETRY; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; QUALITY OF LIFE IN EPILEPSY 10; QUALITY OF LIFE IN EPILEPSY 31; QUALITY OF LIFE IN EPILEPSY INVENTORY 89; RATING SCALE; RECALL; RECOGNITION; RELIABLE CHANGE INDEX; REVIEW; SCORING SYSTEM; SELF CONCEPT; SHORT FORM 36; TREATMENT DURATION; VAGUS NERVE STIMULATION; VERBAL MEMORY; WECHSLER MEMORY SCALE; WELLBEING; WORD RECOGNITION; ANIMAL; BRAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY;

ALZHEIMER DISEASE; ANIMALS; BRAIN; COGNITION; HUMANS; MEMORY; VAGUS NERVE STIMULATION;

EID: 84901491273     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.05.005     Document Type: Review

References (75)

1. Agostoni E., Chinnock J.E., De Daly M.B., Murray J.G. Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat. J. Physiol. 1957, 135:182-205.
2. Alonso-Vanegas M.A., Austria-Velasquez J., Lopez-Gomez M., Brust-Mascher E. Chronic intermittent vagal nerve stimulation in the treatment of refractory epilepsy: experience in Mexico with 35 cases. Cirurgia y Cirujanos 2010, 78:15-23.
3. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., van Bockstaele E., Pieribone V., Shiekhattar R., Akaoka H., Drolet G., Astier B., et al. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res. 1991, 88:47-75.
4. Attems J., Thal D.R., Jellinger K.A. The relationship between subcortical tau pathology and Alzheimer's disease. Biochem. Soc. Trans. 2012, 40:711-715.
5. Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J. Clin. Neurophysiol. 2001, 18:415-418.
6. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol. 2002, 1:477-482.
7. Bernstein E., Kaye D., Abrutyn E., Gross P., Dorfman M., Murasko D.M. Immune response to influenza vaccination in large healthy elderly population. Vaccine 1999, 17:82-94.
8. Bondareff W., Mountjoy C.Q., Roth M., Rossor M.N., Iversen L.L., Reynolds G.P., Hauser D.L. Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1987, 1:256-262.
9. Boon P., Vonck K., de Reuck J., Caemaert J. Vagus nerve stimulation for refractory epilepsy. Seizure 2002, 11A:448-455.
10. Borghetti D., Pizzanelli C., Maritato P., Fabbrini M., Jensen S., Iudice A., Murri L., Sartucci F. Mismatch negativity analysis in drug-resistant epileptic patients implanted with vagus nerve stimulator. Brain Res. Bull. 2007, 73:81-85.
11. Braak H., Del Tredici K. Where, when and in what form does sporadic Alzheimer's disease begin?. Curr. Opin. Neurol. 2012, 25:708-714.
12. Brown R.A., Walling S.G., Milway J.S., Harley C.W. Locus ceruleus activation suppresses feedforward interneurons and reduces beta-gamma electroencephalogram frequencies while it enhances theta frequencies in rat dentate gyrus. J. Neurosci. 2005, 25:1985-1991.
13. Clark K.B., Krahl S.E., Smith D.C., Jensen R.A. Post-training unilateral vagal stimulation enhances retention performance in the rat. Neurobiol. Learn. Mem. 1995, 63:213-216.
14. Clark K.B., Naritoku D.K., Smith D.C., Browning R.A., Jensen R.A. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat. Neurosci. 1999, 2:94-98.
15. Contreras R.J., Beckstead R.M., Norgren R. The central projections of the trigeminal, facial, glossopharyngeal and vagus nerves: an autoradiographic study in the rat. J. Auton. Nerv. Syst. 1982, 6:303-322.
16. Cramer J.A. Exploration of changes in health-related quality of life after 3 months of vagus nerve stimulation. Epilepsy Behav. 2001, 2:460-465.
17. Daulatzai M.A. Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenic cascade of Alzheimer's dementia - a novel hypothesis. Neurochem. Res. 2012, 37:846-868.
18. Dodrill C.B., Morris G.L. Effects of vagus nerve stimulation on cognition and quality of life in epilepsy. Epilepsy Behav. 2001, 2:46-53.
19. Dorr A.E., Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J. Pharmacol. Exp. Ther. 2006, 318:890-898.
20. Engelborghs S., Le Bastardl N. The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease. Mol. Diagn. Ther. 2012, 16:135-141.
21. Ergene E., Behr P.K., Shih J.J. Quality-of-life assessment in patients treated with vagus nerve stimulation. Epilepsy Behav. 2001, 2:284-287.
22. Erlanger J., Gasser H.S. Electrical Signs of Nervous Activity 1937, University of Pennsylvania Press, Philadelphia.
23. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 2000, 51:245-270.
24. Follesa P., Biggio F., Gorini G., Caria S., Talani G., Dazzi L., Puligheddu M., Marrosu F., Biggio G. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res. 2007, 1179:28-34.
25. Foley J.O., DuBois F. Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory to motor fibers. J. Comp. Neurol. 1937, 67:49-97.
26. Frey S., Bergado-Rosado J., Seidenbecher T., Pape H.-C., Frey J.U. Reinforcement of early long-term potentiation (early-LTP) in dentate gyrus by stimulation of the basolateral amygdala: heterosynaptic induction mechanisms of late-LTP. J. Neurosci. 2001, 21:3697-3703.
27. Gavrilyuk V., Dello R.C., Heneka M.T., Pelligrino D., Weinberg G., Feinstein D.L. Norepinephrine increases IκBα expression in astrocytes. J. Biol. Chem. 2002, 277:29662-29668.
28. Ghacibeh G.A., Shenker J.I., Shenal B., Uthman B.M., Heilman K.M. The influence of vagus nerve stimulation on memory. Cogn. Behav. Neurol. 2006, 19:119-122.
29. Ghacibeh G.A., Shenker J.I., Shenal B., Uthman B.M., Heilman K.M. Effect of vagus nerve stimulation on creativity and cognitive flexibility. Epilepsy Behav. 2006, 8:720-725.
30. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelley K.W., Johnson R.W. Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system. FASEB J. 2005, 19:1329-1353.
31. Gravenstein S., Drinka P., Duthie E.H., Miller B.A., Brown C.S., Hensley M., Circo R., Langer E., Ershler W.B. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak. J. Am. Geriatr. Soc. 1994, 42:245-251.
32. Groves D.A., Bowman E.M., Brown V.J. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci. Lett. 2005, 379:174-179.
33. Grudzien A., Shaw P., Weintraub S., Bigio E., Mash D.C., Mesulam M.M. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol. Ageing 2007, 28:327-335.
34. Haas H.L., Rose G.M. Noradrenaline blocks potassium conductance in rat dentate granule cells in vitro. Neurosci. Lett. 1987, 78:171-174.
35. Harding R., Leek B.F. Central projections of gastric afferent vagal inputs. J. Physiol. 1973, 228:73-90.
36. Harley C.W. Norepinephrine and the dentate gyrus. Prog. Brain Res. 2007, 163:299-318.
37. Hassert D.L., Miyashita T., Williams C.L. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav. Neurosci. 2004, 118:79-88.
38. Helmstaedter C., Hoppe C., Elger C.E. Memory alterations during high-intensity vagus nerve stimulation. Epilepsy Res. 2001, 47:37-42.
39. Heneka M.T., Nadrigny F., Regen T., Martinez-Hernandez A., Dumitrescu-Ozimek L., Terwel D., Jardanhazi-Kurutz D., Walter J., Kirchhoff F., Hanisch U.-K., Kummer M.P. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6058-6063.
40. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines. Brain Behav. Immun. 2009, 23:309-317.
41. Hermann G.E., Emch G.S., Tovar C.A., Rogers R.C. C-Fos generation in the dorsal vagal complex after systemic endotoxin is not dependent on the vagus nerve. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 283:G634-G639.
42. Hopkins W.F., Johnston D. Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus. J. Neurophysiol. 1988, 59:667-687.
43. Hoppe C., Helmstaedter C., Scherrmann J., Elger C.E. No evidence for cognitive side effects after 6 months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav. 2001, 2:351-356.
44. Hoppe C., Wagner L., Hoffmann J.M., von Lehe M., Elger C.E. Comprehensive long-term outcome of best drug treatment with our without add-on vagus nerve stimulation for epilepsy: a retrospective matched pairs case-control study. Seizure - Eur. J. Epilepsy 2013, 22:109-115.
45. Jones B.E., Moore R.Y. Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res. 1977, 127:25-53.
46. Klinkenberg S., Majoie H.J.M., van der Heijden M.M.A.A., Rijkers K., Leenen L., Aldenkam A.P. Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy. Clin. Neurol. Neurosurg. 2012, 114:336-340.
47. Lacaille J.C., Harley C.W. The action of norepinephrine in the dentate gyrus: mediated facilitation of evoked potentials in vitro. Brain Res. 1985, 358:210-220.
48. Loy R., Koziell D.A., Lindsey J.D., Moore R.Y. Noradrenergic innervation of the adult rat hippocampal formation. J. Comp. Neurol. 1980, 189:699-710.
49. Martlé V., Raedt R., Clinckers R., Vonck K., Boon P., Van Ham L., Peremans K., Duchateau L., Waelbers T., Bhatti S. Acute vagus nerve stimulation increases norepinephrine levels in the cerebrospinal fluid of Beagle dogs. J. Vet. Intern. Med. 2011, (abstract).
50. Martin C.O., Denburg N.L., Tranel D., Granner M.A., Bechara A. The effect of vagus nerve stimulation on decision making. Cortex 2004, 40:605-612.
51. Mason S.T., Fibiger H.C. Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase. J. Comp. Neurol. 1979, 187:703-724.
52. McGlone J., Valdivia I., Penner M., Williams J., Sadler R.M., Clarcke D.B. Quality of life and memory after vagus nerve stimulator implantation for epilepsy. Can. J. Neurol. Sci. 2008, 35:287-296.
53. McIntyre C.K., McGaugh J.L., Williams C.L. Interacting brain systems modulate memory consolidation. Neurosci. Biobehav. Rev. 2012, 36:1750-1762.
54. McMillan P.J., White S.S., Franklin A., Greenup J.L., Leverenz J.B., Raskind M.A., Szot P. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease. Brain Res. 2011, 1373:240-252.
55. Merrill C.A., Jonsson M.A.G., Minthon L., Ejnell H., Silander H.C., Blennow K., Karlsson M., Nordlund E., Sjögren M.J.C. Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J. Clin. Psychiatry 2006, 67:1171-1178.
56. Mueller D., Porter J.T., Quirk G.J. Noradrenergic signalling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J. Neurosci. 2008, 28:369-375.
57. Mynlieff M., Dunwiddie T.V. Noradrenergic depression of synaptic responses in hippocampus of rat: evidence for mediation by alpha 1-receptors. Neuropharmacology 1988, 27:391-398.
58. Nakamura S., Iwama K. Antidromic activation of the rat locus coeruleus neurons from hippocampus, cerebral and cerebellar cortices. Brain Res. 1975, 99:372-376.
59. Ogata K., Yokose N., Tamura H., An E., Nakamura K., Dan K., Nomura T. Natural killer cells in the late decades of human life. Clin. Immunol. Immunopathol. 1997, 84:269-275.
60. Patel N.J., Chen M.J., Russo-Neustadt A.A. Norepinephrine and nitric oxide promote cell survival signalling in hippocampus neurons. Eur. J. Pharmacol. 2010, 633:1-9.
61. Pickel V.M., Segal M., Bloom F.E. A radioautographic study of the efferent pathways of the nucleus locus coeruleus. J. Comp. Neurol. 1974, 155:15-42.
62. Raedt R., Clinckers R., Mollet L., Vonck K., El Tahry R., Wyckhuys T., De Herdt V., Carette E., Wadman W., Michotte Y., Smolders I., Boon P., Meurs A. Increased hippocampus noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J. Neurochem. 2011, 117(3):461-469.
63. Revesz D., Tjernstrom M., Ben-Menachem E., Thorlin T. Effects of vagus nerve stimulation on rat hippocampus progenitor proliferation. Exp. Neurol. 2008, 214:259-265.
64. Roosevelt R.W., Smith D.C., Clough R.W., Jensen R.A., Browning R.A. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res. 2006, 1119:124-132.
65. Ruffoli R., Giorgi F.S., Pizzanelli C., Murri L., Paparelli A., Fornai F. The chemical neuroanatomy of vagus nerve stimulation. J. Chem. Neuroanat. 2011, 42:288-296.
66. Sackheim H.A., Keilp J.G., Rush J., George M.S., Marangell L.B., Dormer J.S., Burt T., Lisanby S.H., Husain M., Cullum M., Oliver N., Zboyan H. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol. Behav. Neurol. 2001, 14:53-62.
67. Sakai K., Salvert D., Touret M., Jouvet M. Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res. 1977, 137:11-35.
68. Schachter S.C., Saper C.B. Vagus nerve stimulation. Epilepsia 1998, 39:677-686.
69. Sjögren M.J.C., Hellström P.T.O., Jonsson M.A.G., Runnersatm M., Silander H.C., Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J. Clin. Psychiatry 2002, 63:972-980.
70. Stanton P.K., Sarvey J.M. Blockade of norepinephrine-induced long-lasting potentiation in the rat hippocampal dentate gyrus by an inhibitor of protein synthesis. Brain Res. 1985, 361:276-283.
71. Stefan H., Kreiselmeyer G., Kerling F., Kurzbuch K., Rauch C., Heers M., Kasper B.S., Hammen T., Rzonsa M., Pauli E., Ellrich J., Graf W., Hopfengärtner R. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia 2012, 53:e115-e118.
72. Takayama K., Ishikawa N., Miura M. Sites of origin and termination of gastric vagus preganglionic neurons: an HRP study in the rat. J. Auton. Nerv. Syst. 1982, 6:211-223.
73. Van Bockstaele E.J., Peoples J., Telegan P. Efferent projections of the nucleus of the solitary tract to peri-locus coeruleus dendrites in rat brain: evidence for a monosynaptic pathway. J. Comp. Neurol. 1999, 412:410-428.
74. Weinshenker D. Functional consequences of locus coeruleus degeneration in Alzheimer's disease. Curr. Alzheimer Res. 2008, 5:342-345.
75. Zuo Y., Smith D.C., Jensen R.A. Vagus nerve stimulation potentiates hippocampal LTP in freely-moving rats. Psychol. Behav. 2007, 90:583-589.